Infarct growth rate and tenecteplase benefit in ischemic stroke at 4.5 to 24 h without thrombectomy—A secondary analysis of the TRACE-III randomized trial
Liyuan Wang(Weifang Medical University), Yunyun Xiong(Capital Medical University), Aoming Jin(National Clinical Research Center for Digestive Diseases), Li Zhou(Weifang People's Hospital), MJ Fisher(Beth Israel Deaconess Medical Center), Manjun Hao(Harbin Medical University), Bruce Campbell(The Royal Melbourne Hospital), Zhixin Cao(Capital Medical University), Hao Wang(Capital Medical University), Shuangzhe Wu(Harbin Medical University), Wanxing Ye(Harbin Medical University), Hongguo Dai, Jinfeng Yin(National Clinical Research Center for Digestive Diseases), Lee Schwamm(Yale New Haven Health System), Xia Meng(National Clinical Research Center for Digestive Diseases), Mark Parsons(Liverpool Hospital), Yongjun Wang(Capital Medical University), Fengyuan Che(Linyi People's Hospital), Ziran Wang(Linyi People's Hospital), Chunmiao Duan(Capital Medical University), Lihua Wang(Harbin Medical University), Lixia Zong(Harbin Medical University)
Cited by 0
Related Papers
Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials
|The Lancet|2016|7.6k
Endovascular Therapy for Ischemic Stroke with Perfusion-Imaging Selection
|New England Journal of Medicine|2015|5.8k
Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study
|The Lancet|2018|1.8k
Ischaemic stroke
|Nature Reviews Disease Primers|2019|1.7k
Thrombolysis Guided by Perfusion Imaging up to 9 Hours after Onset of Stroke
|New England Journal of Medicine|2019|1k